Researchers at Rush University Medical Center have found that opioid use might increase a person’s risk of developing pancreatic cancer. Published Jan. 6, the study, titled “Opioid Use as a Potential Risk Factor for Pancreatic Cancer in the United States,” is the first in the country to show evidence that opioid use may be an … Continued
The Rush University Cancer Center recently earned a three-year reaccreditation from the Commission on Cancer, a program of the American College of Surgeons dedicated to improving patient outcomes and quality of life through standard setting, research and education. The Commission on Cancer recognizes cancer programs that offer multidisciplinary, patient-centered treatments and address the full continuum … Continued
Despite remarkable advances in the detection and treatment of colorectal cancer, it remains the second-largest cause of cancer mortality in the United States. This statistic looms even though colorectal cancer is one of the most treatable cancers there is because early detection, thus cure, is entirely possible. What makes this unique among the other cancers for … Continued
For the second consecutive time, Rush Copley’s radiation oncology program has been awarded a three-year accreditation from the American College of Radiology, or ACR. Radiation oncology, or radiation therapy, is the use of high-energy radiation to treat cancer. “Rush Copley offers the most advanced radiation therapies, including stereotactic body radiation therapy and high-dose rate brachytherapy, which allow … Continued
By Dan Dean When children and young adults are diagnosed with rare diseases, they and their families often aren’t sure where to turn for answers. The treatments that could be helpful might not come until years later, making a diagnosis in the here and now even more grim. For years, patients diagnosed with fibrolamellar cancer … Continued
